Simulations Plus(SLP)2025-01-07 21:06Revenue Growth - Total revenue increased by 31% year-over-year to $18.9 million, driven primarily by strong software growth[1] - Software revenue grew by 41% to $10.7 million, representing 57% of total revenue, while services revenue increased by 19% to $8.2 million, accounting for 43% of total revenue[6] - The company expects fiscal 2025 revenue guidance to be between $90 million and $93 million, with a revenue growth rate of 28% to 33%[5] - Total revenue for FY24 reached $70.013 million, with Q1 revenue at $14.500 million and Q4 revenue at $18.664 million, showing a steady growth throughout the year[23] - Software revenue accounted for $41.024 million in FY24, with Q2 showing the highest quarterly revenue of $11.614 million[23] - The Americas region generated $50.473 million in revenue for FY24, accounting for the majority of total revenue[23] Profitability - The company achieved a gross profit of $10.2 million, resulting in a gross margin of 54%[6] - Net income for the quarter was $0.2 million, with diluted EPS of $0.01, compared to net income of $1.9 million and diluted EPS of $0.10 in the same quarter last year[6] - Adjusted EBITDA was $4.5 million, representing 24% of total revenue, compared to $3.4 million or 23% of total revenue in the prior year[6] - Adjusted EBITDA for FY24 was $20.257 million, with Q2 contributing $7.135 million, indicating strong operational performance[25] - Net income for FY24 totaled $9.954 million, with Q2 net income at $4.029 million, reflecting a significant increase compared to other quarters[27] - Adjusted diluted EPS for FY24 was $0.95, with Q2 adjusted diluted EPS at $0.32, reflecting improved profitability[27] Operational Performance - The gross margin for total revenue in FY24 was 61.6%, with software gross margin at 84.2% and services gross margin at 29.7%[23] - Cash flow from operations for FY24 was $13.320 million, with Q2 cash flow at $5.810 million, indicating strong liquidity[23] - The backlog for services stood at $17.254 million in Q1 FY25, showing a healthy pipeline for future revenue[23] Business Unit Performance - MonolixSuite™ contributed significantly with a growth rate of 43%, and the Quantitative Systems Pharmacology (QSP) business unit saw a 40% growth due to strong demand in specific disease areas[3] - Services revenue faced temporary headwinds due to client-driven data delays, but bookings were strong in Clinical Pharmacology & Pharmacometrics and Medical Communications[4] - The integration of Adaptive Learning and Insights (ALI) and Medical Communications (MC) business units is progressing well, with expectations for stronger momentum in the latter half of fiscal 2025[5] Customer Metrics - The average revenue per customer in the commercial segment was $94.0 thousand in Q1 FY25, demonstrating an increase from previous quarters[23]